# Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation

> **NCT01071486** · PHASE4 · WITHDRAWN · sponsor: **Rambam Health Care Campus**

## Conditions studied

- Busulfan Pharmacokinetic Analysis
- GST Genetic Polymorphism

## Interventions

- **DRUG:** Hematological Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT01071486
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of participants
- **Last updated:** 2015-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071486, "Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01071486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*